Merck KGaA Stock Wiener Boerse

Equities

MRCK

DE0006599905

Pharmaceuticals

End-of-day quote Wiener Boerse 18:00:00 2024-05-22 EDT 5-day change 1st Jan Change
169.2 EUR +0.62% Intraday chart for Merck KGaA +1.05% +18.37%

Financials

Sales 2024 * 21.27B 23.06B 31.51B Sales 2025 * 22.54B 24.44B 33.39B Capitalization 72.93B 79.08B 108B
Net income 2024 * 2.98B 3.23B 4.42B Net income 2025 * 3.5B 3.8B 5.19B EV / Sales 2024 * 3.72 x
Net Debt 2024 * 6.28B 6.81B 9.3B Net Debt 2025 * 4.45B 4.82B 6.59B EV / Sales 2025 * 3.43 x
P/E ratio 2024 *
24.2 x
P/E ratio 2025 *
20.5 x
Employees 62,345
Yield 2024 *
1.33%
Yield 2025 *
1.44%
Free-Float 29.71%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.62%
1 week+1.05%
Current month+13.52%
1 month+12.65%
3 months+6.52%
6 months+5.19%
Current year+18.37%
More quotes
1 week
165.75
Extreme 165.75
170.20
1 month
149.00
Extreme 149
170.20
Current year
141.30
Extreme 141.3
170.20
1 year
135.35
Extreme 135.35
170.55
3 years
135.35
Extreme 135.35
231.20
5 years
80.68
Extreme 80.68
231.20
10 years
74.82
Extreme 74.82
231.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 20-07-12
Director of Finance/CFO 56 14-07-31
Director of Finance/CFO 53 19-04-25
Members of the board TitleAgeSince
Director/Board Member - -
Director/Board Member 61 12-04-30
Director/Board Member 62 90-12-31
More insiders
Date Price Change
24-05-24 167.8 -0.80%
24-05-23 169.2 +0.62%
24-05-22 168.1 +1.42%
24-05-21 165.8 -0.18%
24-05-20 166 -0.81%

End-of-day quote Wiener Boerse, May 22, 2024

More quotes
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
167.8 EUR
Average target price
182.9 EUR
Spread / Average Target
+9.05%
Consensus